MedTech Acquisition (MTAC) Return on Equity (ROE) (2021 - 2023)
MedTech Acquisition (MTAC) Return on Equity (ROE) from Mar 31, 2021 to Jun 30, 2023. The TTM MedTech Acquisition (MTAC) Return on Equity (ROE) is 92.42%. You can export chart.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of MedTech Acquisition (MTAC)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2022 | 26.76% | -193.81% |
| 2021 | -28.53% | N/A |